AbCellera Announces Virtual Presentations at Investor Conferences in November
November 04 2021 - 4:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present at the following virtual investor
conferences:
- Credit Suisse 30th Annual Virtual Healthcare Conference on
Thursday, November 11 at 7:30 a.m. Pacific Time
- Stifel 2021 Virtual Healthcare Conference on Tuesday, November
16 at 10:20 a.m. Pacific Time
- Piper Sandler 33rd Annual Virtual Healthcare Conference on
Tuesday, November 30 (recorded and available on November 22)
Live audio webcasts of the Credit Suisse and Stifel
presentations may be accessed through links that will be posted on
AbCellera’s Investor Relations website. A replay of all three
recordings will be available at the same location following the
presentations.
About AbCellera Biologics Inc.
AbCellera is a technology company that searches, decodes, and
analyzes natural immune systems to find antibodies that its
partners can develop into drugs to prevent and treat disease.
AbCellera partners with drug developers of all sizes, from large
pharmaceutical to small biotechnology companies, empowering them to
move quickly, reduce costs, and tackle the toughest problems in
drug development. For more information, please visit
www.abcellera.com
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211104006242/en/
Media: Jessica Yingling, Ph.D.; media@abcellera.com,
+1(236)521-6774 Business Development: Neil Berkley;
bd@abcellera.com, +1(604)559-9005 Investor Relations: Melanie
Solomon; ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Apr 2023 to Apr 2024